SKI Market

Indian Indices

Sensex

80,722.94 -1,546.84
( -1.88%)

Global Indices

Nasdaq

48,928.31 -164.26
(-0.33%)

Dow Jones

6,963.16 -26.85
(-0.38%)

Hang Seng

53,392.10 16.50
(0.03%)

Nikkei 225

10,214.90 43.14
(0.42%)

Forex

USD-INR

91.92 0.08
(0.09%)

EUR-INR

109.97 0.03
(0.03%)

GBP-INR

126.94 0.27
(0.21%)

JPY-INR

0.60 0.00
(0.00%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.5329749

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

218.75

48.83

EPS(TTM)

Face Value()

Div & Yield %

0.16

Back

IRB InvIT Fund consolidated net profit declines 3.05% in the September 2025 quarter

Nov 14,2025

Net profit of IRB InvIT Fund declined 3.05% to Rs 82.74 crore in the quarter ended September 2025 as against Rs 85.34 crore during the previous quarter ended September 2024. Sales rose 2.42% to Rs 276.60 crore in the quarter ended September 2025 as against Rs 270.06 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	276.60	270.06	2
OPM %	83.72	82.84	-
PBDT	158.95	151.66	5
PBT	87.34	87.96	-1
NP	82.74	85.34	-3

80,722.94 -1,546.84 ( -1.88%)

48,928.31 -164.26 (-0.33%)

6,963.16 -26.85 (-0.38%)

53,392.10 16.50 (0.03%)

10,214.90 43.14 (0.42%)

91.92 0.08 (0.09%)

109.97 0.03 (0.03%)

126.94 0.27 (0.21%)

0.60 0.00 (0.00%)